We simultaneously supplied RA during IL-17 and IFNγ mediated TA-MSC transformation, and further performed co-engrafted cell-derived xenograft experiments with B16F0 melanoma cells and transformed TA-MSCs or RA treated TA-MSCs (Figure 3A). This evidence concerns the gene IFNG and melanoma.